Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 148.00
+2.00 (1.37%)
Jun 19, 2026, 8:27 AM GMT
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 123.62 million as of June 18, 2026. Its market cap has increased by 13.36% in one year.
Market Cap
123.62M
Enterprise Value
117.43M
Revenue
38.44M
Ranking
n/a
PE Ratio
1,274.42
Stock Price
148.00
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 123.62M, an increase of 86.03%. That is a compound annual growth rate of 8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 123.62M | 13.74% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 204.02B |
| GSK plc | 78.74B |
| Haleon | 29.64B |
| Smith & Nephew | 9.61B |
| Tristel | 184.75M |
| EKF Diagnostics Holdings | 116.24M |
| INSPECS Group | 102.18M |
| Bioventix | 95.35M |